Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOT™. TB assay

European Respiratory Journal

Volumn 29, Issue 3, 2007, Pages 605-607

  van Leeuwen, R M L ^a   Bossink, Aik W J ^a,b   Thijsen, S F T ^a  

^a DEPARTMENT OF SURGERY   (Netherlands)

^b NONE   (Netherlands)

Author keywords

ELISPOT assay; Interferon releasing assay; Nontuberculous mycobacteria; Tuberculin skin test; Tuberculosis

Indexed keywords

AZATHIOPRINE; BCG VACCINE; CLARITHROMYCIN; ETHAMBUTOL; PREDNISOLONE; RIFAMPICIN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BRONCHOSCOPY; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL NEPHRITIS; LABORATORY TEST; LUNG LAVAGE; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM GENAVENSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT DURATION; TUBERCULIN TEST;

ADOLESCENT; AGED; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TUBERCULOSIS, PULMONARY;

EID: 33847723103     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00066506     Document Type: Article

References (13)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. Consensus Statement: WHO Global Surveillance and Monitoring Project. JAMA 1999; 282: 677-686.
2. Anonymous. Royal Netherlands Tuberculosis Association (KNCV) Index Tuberculosis 2001-2002. ISDN90-77865-01-2. The Hague, 2004.
3. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-238.
4. Borgdorff MW, van der Werf MJ, de Haas PE, Kremer K, van Soolingen D. Tuberculosis elimination in the Netherlands. Emerg Infect Dis 2005; 11: 597-602.
5. McNeill L, Allen M, Estrada C, Cook P. Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity. Chest 2003; 123: 102-106.
6. Pai M, Riley LW, Colford JM Jr. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4: 761-776.
7. Lalvani A, Pathan AA, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001; 357: 2017-2021.
8. Lalvani A, Pathan AA, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001; 163: 824-828.
9. Chapman A, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002; 16: 2285-2293.
10. Arend S, van Meijgaarden KE, de Boer K, et al. Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis 2002; 186: 1797-1807.
11. Reischl U, Lehn N, Wolf H, Naumann L. Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens. J Clin Microbiol 1998; 36: 2853-2860.
12. Meier T, Eulenbruch H-P, Wrighton-Smith P, Enders G, Regnath T. Sensitivity of a new commercial enzyme-linked. immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 2005; 24: 529-536.
13. Ferrara G, Losi M, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367: 1328-1334.